Skip to content

Reference

Evidence

CompoundsSubstances with curated findings
OutcomesMeasured endpoints
ProteinsTransporters and enzymes
InteractionsPairs that share biology
PapersEvery paper a finding cites
ArticlesReadings of the evidence

Chemistry

ReactionsRhea and Human-GEM, by subsystem
ReachWhat a compound can become

Reference layer

PathwaysReactions grouped under one name
ProcessesWhat proteins are annotated as doing
AnatomyTissues, by what is expressed there
Cell typesCells, by what is expressed there
OrganismsSpecies a compound is prepared from
MaterialsSubstances that are not one molecule
AssessmentsRegulatory determinations, transcribed
DiseasesFeatures, genes, and where each sits

Atlas Graph Twin Access

Search the graph

Reference

Evidence

Compounds
Outcomes
Proteins
Interactions
Papers
Articles

Chemistry

Reactions
Reach

Reference layer

Pathways
Processes
Anatomy
Cell types
Organisms
Materials
Assessments
Diseases

Atlas Graph Twin Access

Loading the page.

Catalyst

Computational infrastructure for human biology, built on a provenance-aware knowledge graph. Findings retain their sources; research and simulation are the next layers.

The graph

Compounds
Outcomes
Proteins
Atlas
Interactions
Papers
Articles
Graph
Search

Reference layer

Pathways
Processes
Anatomy
Cell types
Organisms
Materials
Assessments
Diseases
Reactions
Reach

How it works

Mission
Method
Twin
How to read the evidence
Sources and licences

Build on it

Access
In your assistant
For agents
Query the graph
Bulk export

A reference for what the literature reports. Not medical advice.

© 2026 CatalystPrivacy TermsReference data under the licences listed on the attribution page.

Index

Pathways

Names from Reactome and WikiPathways

pathways in the graph: 3,812

Filter pathways by name

#a b c d e f g h i j k l m n o p q r s t u v w x y z

3,401–3,500 of 3,812, alphabetically

Synthesis of bile acids and bile salts via 24-hydroxycholesterolReactomeR-HSA-193775
Synthesis of bile acids and bile salts via 27-hydroxycholesterolReactomeR-HSA-193807
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterolReactomeR-HSA-193368
Synthesis of ceramides and 1 deoxyceramidesWikiPathways5194
Synthesis of CLReactomeR-HSA-1483076

More of the reference layer

Biological processes
Anatomy
Cell types
Organisms
Materials
Regulatory assessments
Diseases

Evidence: Compounds · Outcomes · Papers · Search

Synthesis of diphthamide-EEF2

ReactomeR-HSA-5358493

Synthesis of DNAReactomeR-HSA-69239

Synthesis of dolichyl-phosphateReactomeR-HSA-446199

Synthesis of dolichyl-phosphate mannoseReactomeR-HSA-162699

Synthesis of dolichyl-phosphate-glucoseReactomeR-HSA-480985

Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)ReactomeR-HSA-2142670

Synthesis of GDP-mannoseReactomeR-HSA-446205

Synthesis of glycosylphosphatidylinositol (GPI)ReactomeR-HSA-162710

Synthesis of Hepoxilins (HX) and Trioxilins (TrX)ReactomeR-HSA-2142696

Synthesis of IP2, IP, and Ins in the cytosolReactomeR-HSA-1855183

Synthesis of IP3 and IP4 in the cytosolReactomeR-HSA-1855204

Synthesis of IPs in the ER lumenReactomeR-HSA-1855231

Synthesis of IPs in the nucleusReactomeR-HSA-1855191

Synthesis of Ketone BodiesReactomeR-HSA-77111

Synthesis of Leukotrienes (LT) and Eoxins (EX)ReactomeR-HSA-2142691

Synthesis of PAReactomeR-HSA-1483166

Synthesis of PCReactomeR-HSA-1483191

Synthesis of PEReactomeR-HSA-1483213

Synthesis of PGReactomeR-HSA-1483148

Synthesis of PIReactomeR-HSA-1483226

Synthesis of PIPs at the early endosome membraneReactomeR-HSA-1660516

Synthesis of PIPs at the ER membraneReactomeR-HSA-1483248

Synthesis of PIPs at the Golgi membraneReactomeR-HSA-1660514

Synthesis of PIPs at the late endosome membraneReactomeR-HSA-1660517

Synthesis of PIPs at the plasma membraneReactomeR-HSA-1660499

Synthesis of PIPs in the nucleusReactomeR-HSA-8847453

Synthesis of Prostaglandins (PG) and Thromboxanes (TX)ReactomeR-HSA-2162123

Synthesis of PSReactomeR-HSA-1483101

Synthesis of pyrophosphates in the cytosolReactomeR-HSA-1855167

Synthesis of substrates in N-glycan biosythesisReactomeR-HSA-446219

Synthesis of UDP-N-acetyl-glucosamineReactomeR-HSA-446210

Synthesis of very long-chain fatty acyl-CoAsReactomeR-HSA-75876

Synthesis of wybutosine at G37 of tRNA(Phe)ReactomeR-HSA-6782861

Synthesis, secretion, and deacylation of GhrelinReactomeR-HSA-422085

Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)ReactomeR-HSA-381771

Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)ReactomeR-HSA-400511

T cell activation SARS CoV 2WikiPathways5098

T cell antigen receptor TCR pathway during Staphylococcus aureus infectionWikiPathways3863

T cell modulation and desmoplasia in pancreatic cancerWikiPathways5078

T cell receptor and co stimulatory signalingWikiPathways2583

T cell receptor signalingWikiPathways69

t(4;14) translocations of FGFR3ReactomeR-HSA-2033515

Tachykinin receptors bind tachykininsReactomeR-HSA-380095

TAK1-dependent IKK and NF-kappa-B activationReactomeR-HSA-445989

TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3PReactomeR-HSA-6791462

TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4PReactomeR-HSA-6791055

tamatinib-resistant FLT3 mutantsReactomeR-HSA-9703009

Tamoxifen metabolismWikiPathways691

Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)ReactomeR-HSA-1299308

Tandem pore domain halothane-inhibited K+ channel (THIK)ReactomeR-HSA-1299287

Tandem pore domain potassium channelsReactomeR-HSA-1296346

tandutinib-resistant FLT3 mutantsReactomeR-HSA-9702636

TAR syndromeWikiPathways5362

Target of rapamycin signalingWikiPathways1471

Targeted agents in triple negative breast cancerWikiPathways5215

Targeted therapy in breast cancerWikiPathways5496

Targeting YAP in pancreatic ductal adenocarcinoma PDAC WikiPathways5495

Tat-mediated elongation of the HIV-1 transcriptReactomeR-HSA-167246

Tat-mediated HIV elongation arrest and recoveryReactomeR-HSA-167243

TBC/RABGAPsReactomeR-HSA-8854214

TCA cycle aka Krebs or citric acid cycle WikiPathways78

TCA cycle and deficiency of pyruvate dehydrogenase complex PDHc WikiPathways2453

TCA cycle in senescenceWikiPathways5050

TCA cycle nutrient use and invasiveness of ovarian cancerWikiPathways2868

TCF dependent signaling in response to WNTReactomeR-HSA-201681

TCR signalingReactomeR-HSA-202403

Telomere C-strand (Lagging Strand) SynthesisReactomeR-HSA-174417

Telomere C-strand synthesis initiationReactomeR-HSA-174430

Telomere end packaging and neurodevelopmental disordersWikiPathways5567

Telomere Extension By TelomeraseReactomeR-HSA-171319

Telomere MaintenanceReactomeR-HSA-157579

Terminal pathway of complementReactomeR-HSA-166665

Termination of O-glycan biosynthesisReactomeR-HSA-977068

Termination of translesion DNA synthesisReactomeR-HSA-5656169

Tessadori Bicknell van Haaften syndrome 3 overview pathwayWikiPathways5575

Tessadori Bicknell van Haaften syndrome variants nucleosome assemblyWikiPathways5573

TET1,2,3 and TDG demethylate DNAReactomeR-HSA-5221030

Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulationReactomeR-HSA-1474151

TFAP2 (AP-2) family regulates transcription of cell cycle factorsReactomeR-HSA-8866911

TFAP2 (AP-2) family regulates transcription of growth factors and their receptorsReactomeR-HSA-8866910

TFAP2 (AP-2) family regulates transcription of other transcription factorsReactomeR-HSA-8866906

TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiationReactomeR-HSA-8869496

TGF 1 SMAD2 3 signalling in decidual NK cells at the fetal maternal interfaceWikiPathways5637

TGF beta receptor signalingWikiPathways560

TGF beta receptor signaling in skeletal dysplasiasWikiPathways4816

TGF beta signaling in thyroid cells for epithelial mesenchymal transitionWikiPathways3859

TGF-beta receptor signaling activates SMADsReactomeR-HSA-2173789

TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)ReactomeR-HSA-2173791

TGFB Smad signalingWikiPathways5382

TGFBR1 KD Mutants in CancerReactomeR-HSA-3656532

TGFBR1 LBD Mutants in CancerReactomeR-HSA-3656535

TGFBR2 Kinase Domain Mutants in CancerReactomeR-HSA-3645790

TGFBR2 MSI Frameshift Mutants in CancerReactomeR-HSA-3642279

TGFBR3 expressionReactomeR-HSA-9839394

TGFBR3 PTM regulationReactomeR-HSA-9839383

Page 35 of 39

Next First Last